Literature DB >> 7541912

Structural and functional characterization of the promoter regions of the NFKB2 gene.

L Lombardi1, P Ciana, C Cappellini, D Trecca, L Guerrini, A Migliazza, A T Maiolo, A Neri.   

Abstract

In order to clarify the transcriptional regulation of the NFKB2 gene (lyt-10, NF-kappa Bp100), we have characterized the structure and function of its promoter regions. Based on the nucleotide sequence of cDNA clones and the 5' flanking genomic region of the NFKB2 gene, RT-PCR analysis in a number of human cell lines demonstrated the presence of two alternative noncoding first exons (1a and 1b). Two distinct promoter regions, P1 and P2, were identified upstream of each exon, containing multiple sites of transcription initiation, as shown by RNase protection analysis. Sequence analysis of these regions showed a CAAT box upstream of exon 1a and high G-C content regions within both P1 and P2. Consensus binding sites for transcription factors, including SP1, AP1 and putative NF-kappa B (kappa B sites), were found upstream of each exon. In particular, six kappa B sites were identified, all but one of them capable of binding NF-kappa B complexes in vitro. Transfection in HeLa cells of plasmids containing P1 and P2 sequences linked to a chloramphenicol acetyltransferase reporter gene indicated that both P1 and P2 can act independently as promoters. Co-transfection of NF-kappa B effector plasmids (NF-kappa Bp52 and RelA) with a reporter gene linked to P1 and P2 showed that the NFKB2 promoter regions are regulated by NF-kappa B factors. RelA transactivates the NFKB2 promoter in a dose-dependent manner, whereas NF-kappa Bp52 acts as a repressor, indicating that the NFKB2 gene may be under the control of a negative feedback regulatory circuit.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541912      PMCID: PMC307025          DOI: 10.1093/nar/23.12.2328

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  61 in total

1.  Cloning of a mitogen-inducible gene encoding a kappa B DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs.

Authors:  V Bours; J Villalobos; P R Burd; K Kelly; U Siebenlist
Journal:  Nature       Date:  1990-11-01       Impact factor: 49.962

2.  Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal.

Authors:  S Ghosh; A M Gifford; L R Riviere; P Tempst; G P Nolan; D Baltimore
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

Review 3.  The inducible transcription activator NF-kappa B: regulation by distinct protein subunits.

Authors:  P A Baeuerle
Journal:  Biochim Biophys Acta       Date:  1991-04-16

4.  Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B.

Authors:  S M Ruben; P J Dillon; R Schreck; T Henkel; C H Chen; M Maher; P A Baeuerle; C A Rosen
Journal:  Science       Date:  1991-03-22       Impact factor: 47.728

5.  Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65.

Authors:  R M Schmid; N D Perkins; C S Duckett; P C Andrews; G J Nabel
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

6.  Structure and autoregulation of the c-rel promoter.

Authors:  M Hannink; H M Temin
Journal:  Oncogene       Date:  1990-12       Impact factor: 9.867

7.  DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide.

Authors:  G P Nolan; S Ghosh; H C Liou; P Tempst; D Baltimore
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

8.  Lymphoid specific gene expression of the adenovirus early region 3 promoter is mediated by NF-kappa B binding motifs.

Authors:  J L Williams; J Garcia; D Harrich; L Pearson; F Wu; R Gaynor
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

9.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

10.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

View more
  40 in total

1.  Regulation of RelB expression during the initiation of dendritic cell differentiation.

Authors:  Pedro J Cejas; Louise M Carlson; Despina Kolonias; Jian Zhang; Inna Lindner; Daniel D Billadeau; Lawrence H Boise; Kelvin P Lee
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

2.  Maximal adamantyl-substituted retinoid-related molecule-induced apoptosis requires NF-κB noncanonical and canonical pathway activation.

Authors:  L Farhana; M I Dawson; F Murshed; J A Fontana
Journal:  Cell Death Differ       Date:  2010-07-30       Impact factor: 15.828

3.  Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A.

Authors:  Mary Pulvino; Yue Liang; David Oleksyn; Michael DeRan; Elise Van Pelt; Joel Shapiro; Ignacio Sanz; Luojing Chen; Jiyong Zhao
Journal:  Blood       Date:  2012-07-12       Impact factor: 22.113

4.  Constitutive IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice.

Authors:  Katerina Vlantis; Andy Wullaert; Yoshiteru Sasaki; Marc Schmidt-Supprian; Klaus Rajewsky; Tania Roskams; Manolis Pasparakis
Journal:  J Clin Invest       Date:  2011-06-23       Impact factor: 14.808

5.  Loss of negative feedback control of nuclear factor-kappaB2 activity in lymphocytes leads to fatal lung inflammation.

Authors:  Liqun Yang; Hongjuan Cui; Zhe Wang; Baochun Zhang; Jane Ding; Lin Liu; Han-Fei Ding
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

6.  Functional interference of Sp1 and NF-kappaB through the same DNA binding site.

Authors:  F Hirano; H Tanaka; Y Hirano; M Hiramoto; H Handa; I Makino; C Scheidereit
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

7.  Activation of noncanonical NF-kappaB signaling by the oncoprotein Tio.

Authors:  Sarah Jill de Jong; Jens-Christian Albrecht; Monika Schmidt; Ingrid Müller-Fleckenstein; Brigitte Biesinger
Journal:  J Biol Chem       Date:  2010-03-30       Impact factor: 5.157

8.  The nfkb1 promoter is controlled by proteins of the Ets family.

Authors:  P F Lambert; M J Ludford-Menting; N J Deacon; I Kola; R R Doherty
Journal:  Mol Biol Cell       Date:  1997-02       Impact factor: 4.138

9.  RNA-Seq and protein mass spectrometry in microdissected kidney tubules reveal signaling processes initiating lithium-induced nephrogenic diabetes insipidus.

Authors:  Chih-Chien Sung; Lihe Chen; Kavee Limbutara; Hyun Jun Jung; Gabrielle G Gilmer; Chin-Rang Yang; Shih-Hua Lin; Sookkasem Khositseth; Chung-Lin Chou; Mark A Knepper
Journal:  Kidney Int       Date:  2019-03-04       Impact factor: 10.612

10.  B-cell survival and development controlled by the coordination of NF-κB family members RelB and cRel.

Authors:  Jonathan V Almaden; Yi C Liu; Edward Yang; Dennis C Otero; Harry Birnbaum; Jeremy Davis-Turak; Masataka Asagiri; Michael David; Ananda W Goldrath; Alexander Hoffmann
Journal:  Blood       Date:  2016-01-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.